May 29, 2026 | Volume XVII | Issue 22

Baptist Health Foundation announces historic $100 million gift

Baptist Health Foundation recently announced the largest single philanthropic gift in the 66-year history of Baptist Health South Florida: a $100 million donation from internationally recognized optometric physician, inventor, entrepreneur and philanthropist Dr. Herbert (“Herbie”) Wertheim, who views the gift as a continuation of his commitment to public service.

Read More

Trump administration reforms surprise billing dispute resolution

Fierce Healthcare reports:


The Trump administration has finalized a long-awaited overhaul of the system used to settle out-of-network billing disputes between insurers and providers, amid growing criticism that the process is inefficient and susceptible to gaming.


The rule finalized by the HHS and the Labor and Treasury Departments on Thursday is meant to make dispute resolution more streamlined and lower costs for participating companies, regulators said.


It’s also aimed at reducing ineligible claims for payment, which have contributed to snowballing disputes and spurred calls for reform from insurers.


“These final rules seek to maximize benefits to providers, plans, and issuers and to reduce burdens on certified IDR entities,” the departments wrote...

Read More

ER doctor: How pneumonia can suddenly turn deadly

Fox News reports:


The sudden death of Kyle Busch has drawn attention to a rare but devastating medical progression: when pneumonia escalates into fatal sepsis.


An ER doctor spoke with Fox News Digital about how sepsis can trigger a rapid health decline.


"Sepsis is actually not a specific disease or diagnosis, but rather the syndrome that occurs when the body has certain abnormal findings and a presumed infection," said Dr. Kenneth J. Perry, an ER physician.

Read More

What you need to know about new, simple colon cancer screening

WFAA


Dr David Winter on the Shield test -  a new screening method for colon cancer and other cancer detection tests. The Shield test is a liquid biopsy designed to detect colorectal cancer by identifying specific DNA fragments, known as cell-free DNA (cfDNA), shed by tumors into the bloodstream. It is intended for average-risk adults aged 45 and older and is not suitable for individuals with a personal or family history of colorectal cancer, inflammatory bowel disease, or other high-risk conditions.

Watch the video HERE.


Inside

FloridaHealthIndustry.com

Focus

Compliance Update

Best Practices

Healthcare Headlines

Game Changers

Last Word

Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers